Anti-mesothelin CAR T cells

· China Meitan General Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Anti-mesothelin CAR T cells, covering 2016-10-12 to 2016-10-12. Get the full timeline:

Most recent: Clinical Trial Update: Anti-mesothelin CAR T Cells for Patients With Recurrent or Metastatic Malignant Tumors [Phase 1]